InfuSystem (INFU) Form 4 — Shuda Reports Distribution and Sale From Dissolved Partnership
Rhea-AI Filing Summary
InfuSystem Holdings insider Scott Shuda reported changes in beneficial ownership. Mr. Shuda, identified as a director, disclosed indirect ownership of 298,383 shares through entities Meridian and BlueLine. He recorded a distribution on 07/07/2025 that reduced holdings by 2,242 shares and a sale on 08/22/2025 of 5,752 shares at an average price of $9.67 (individual sale prices ranged $9.57–$9.83). Following the reported transactions, the filing shows 94,000 shares owned (direct or indirect) after the August sale. The Form 4 notes the sold shares originated from a dissolved partnership and no further sales are planned relating to that partnership.
Positive
- Transparency: Filing discloses the source of sold shares (dissolved partnership) and offers to provide per-transaction sale prices on request.
- Clarification of control: Reports that Mr. Shuda holds voting and dispositive power over shares held by Meridian and BlueLine.
- No remaining partnership shares: States that no shares remain relating to the dissolved partnership and no further sales are planned for those shares.
Negative
- Insider sales: Sale of 5,752 shares on 08/22/2025 reduces insider-associated holdings and increases free float tied to a director.
- Ownership reduction: Reported post-transaction beneficial ownership appears lower (94,000 shares) than prior indirect totals, reflecting disposals.
Insights
TL;DR: Director reported distribution and small open-market sales from dissolved partnership holdings; beneficial ownership clarified.
The filing clarifies Mr. Shuda's indirect control over 298,383 shares via two investment entities and documents the transfer and sale of partnership-held shares after dissolution of Meridian TSV II, LP. The disclosure helps remove ambiguity about source and disposition of these shares by stating distributions to a former partner and sales for remaining partners. The statement that no partnership-related shares remain and no further sales are planned (with respect to that partnership) materially clarifies ongoing insider supply risk tied to the dissolved vehicle.
TL;DR: Small-volume insider sales at ~$9.57–$9.83 do not by themselves indicate major change to ownership control.
The transactions reported (2,242-share distribution and 5,752-share sale) are modest relative to the total indirect holdings disclosed. The August sale price range is explicitly provided and the filer offers to supply per-transaction prices on request, supporting transparency. The Form 4 includes a clear ownership post-transaction figure (94,000 shares) which investors can use to update holdings tables.
FAQ
What transactions did INFU director Scott Shuda report on Form 4?
How many InfuSystem (INFU) shares does Scott Shuda control indirectly?
Why were the shares sold and where did they originate?
Are there plans for additional sales related to the dissolved partnership?
What price did the August 2025 sales of INFU shares occur at?